Functional tests for adults with asthma: validity, reliability, minimal detectable change and feasibility. Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
What is the minimum clinically important difference in the incremental shuttle walking test (ISWT) observed in pulmonary rehabilitation? Source: Eur Respir J 2002; 20: Suppl. 38, 67s Year: 2002
To study the validity, reliability and acceptability of an audio signal modified shuttle walk test in COPD patients Source: International Congress 2018 – Cardiopulmonary exercise testing in COPD and cardiovascular diseases Year: 2018
The 4-metre gait speed in COPD: responsiveness and minimal clinically important difference Source: Eur Respir J 2014; 43: 1298-1305 Year: 2014
Incremental shuttle walking test: A reproducible and valid measure of exercise tolerance in adult subjects with non-cystic fibrosis bronchiectasis (nCF-BCt) Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations Year: 2013
The AWESCORE, a patient-reported outcome measure: development, feasibility, reliability, validity and responsiveness for adults with cystic fibrosis Source: ERJ Open Res, 7 (3) 00120-2021; 10.1183/23120541.00120-2021 Year: 2021
Reliability and validity of the 10-task physical functional performance test (PFP-10) among patients with COPD Source: Annual Congress 2010 - Outcomes in chronic lung disease: assessing the value of interventions – physical activity, strength and exercise Year: 2010
6-minute walk test (6MWT) in patients with idiopathic pulmonary fibrosis (IPF): Confirmation of the minimal clinically important difference (MCID) Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012
Six minute walk test in children, adolescents and young adults with and without cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: clinical and laboratory studies Year: 2011
Between-day reliability of a novel incremental step test to assess exercise capacity in COPD patients. Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021
Maximal respiratory pressures at functional residual capacity-FRC: test-retest and inter-rater reliability, and comparison to total lung capacity-TLC and residual volume-RV Source: International Congress 2019 – New views on testing and training of respiratory muscles Year: 2019
Minimal clinically important difference in 30 second sit-to-stand test after pulmonary rehabilitation in patients with COPD Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018
The incremental shuttle walk test (ISW) in patients with bronchiectasis: Response to pulmonary rehabilitation (PR) and minimum clinically important difference (MCID) Source: International Congress 2019 – Hot topics in pulmonary rehabilitation Year: 2019
Clinical relevance of constant power exercise duration changes in COPD Source: Eur Respir J 2009; 33: 340-345 Year: 2009
Reliability, construct validity and determinants of 6-minute walk distance in patients with asthma Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD Year: 2021
Differences between six minute walk test values with obstructed and non obstructed cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 698s Year: 2004
Can step be a maximal test in children with cystic fibrosis? Source: Annual Congress 2009 - Paediatric lung function, imaging and methodology in health and disease Year: 2009
Six minute walking test in asthmatic children: reproducibility and correlation with pulmonary function test, strength and endurance of the respiratory muscles Source: Eur Respir J 2004; 24: Suppl. 48, 405s Year: 2004
Six-minute walk test and clinical paramaters in cystic fibrosis: functional assessment instruments Source: Annual Congress 2009 - Physiotherapy aspects in cystic fibrosis and functional assessment Year: 2009
The relationship between the shuttle walk test, lung function and BMI in patients with sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012